Article
Interleukin-37 gene expression is down-regulated in patients with acute myeloid leukemia and shown to be affected by CD14 and HLA-DR immunophenotypes.
Cytokine - 1 Nov 2023
Bashi Mustafa A, Ad'hiah Ali H
Abstract excerpt
Recent evidence has indicated that interleukin 37 (IL-37) shows down-regulated expression in patients with acute myeloid leukemia (AML), but its association with immunophenotypic markers has not been explored. In the current study, IL37 mRNA expression was analyzed in the peripheral blood of 131 AML patients and 100 controls using the 2-ΔΔCt method (fold change), which was based on the principles of quantitative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
